Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report-Reference-Cited by-同舟云学术

Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report

Published:2014-08-15 Issue:1 Volume:7 Page:
ISSN:1756-0500
Container-title:BMC Research Notes
language:en
Short-container-title:BMC Res Notes

Author:

Omar Amr S,Sudarsanan Suraj,Ewila Hesham,Kindawi Ali

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1756-0500-7-535.pdf

Reference18 articles.

1. Al Douri M, Shafi T, Al Khudairi D, Al Bokhari E, Black L, Akinwale N, Andreasen BR: Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis. 2000, 11: S121-S127.

2. Davis R, Whittington R: Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs. 1995, 49: 954-983.

3. Lee J, Costantini TW, Coimbra R: Acute lower GI bleeding for the acute care surgeon: current diagnosis and management. Scand J Surg. 2009, 98 (3): 135-

4. Zahida AS, Al-Shaalan H, Jorgensen J: Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven). Blood Coagul Fibrinolysis. 2006, 17 (4): 327-329.

5. Mitchell JG, Speake WJ, Russell NK, Girling K, Armitage NC: Recombinant factor VIIa: a useful tool for life-threatening colonic bleeding. Report of a case. Dis Colon Rectum. 2007, 50 (12): 2238-2240.